Drug safety update: Gabapentin (Neurontin): risk of severe respiratory depression

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for Gabapentin...
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news